North China Pharmaceutical unit secures key EU GMP certification

North China Pharmaceutical (SSE: 600812) announced that its wholly-owned subsidiary, North China Pharmaceutical Group Xiantai Pharmaceutical Co., Ltd., has received a Good Manufacturing Practice (GMP) compliance certificate from the Spanish Agency of Medicines and Medical Devices (AEMPS). The certification covers the production of penicillin raw materials, including procaine penicillin and benzylpenicillin made at three facilities. It also covers amoxicillin production at one facility, opening the door for sales in the EU. According to the announcement, Xiantai Pharmaceutical has the capacity to produce 560 tons of procaine penicillin products and 160 tons of benzylpenicillin products annually. The company stated that this certification would enable sales to the European market.